Skip to content
×
Support Us
Sign in or register for your free account
Your Profile
Your Subscriptions
Support Local News
Payment History
Sign Out
Registered Users
Already have an account?
Sign In
New Users
Create a free account.
Register
Support Local News
Sign up for Daily Headlines
Sign up for Notifications
Contact Us
Home
News
Local News
Canada Votes 2025
Gibsons News
Sechelt News
shíshálh Nation News
Sunshine Coast ferry news
Sunshine Coast water news
In the Community
Local Sports
BC News
National News
Indigenous News
World News
Real Estate
Business Wire
National Sports
Animal Stories
Digital Edition
Opinion
Opinion
Send us a letter
Arts & Life
Local Arts
Living
Photos and Videos
Automotive
Food
Health
Consumer Technology
The Mix
Events Calendar
More Lifestyes
Features
Weatherhood
Driving
Gas Prices
GuidedBy
Sponsored Content
Special Print Features
Tourist Guide
Spotlight
Homes
Classifieds
View Classified Ads
Place a Classified Ad
Obituaries
Local Obituaries
View Legacy Obituaries
Place an Obituary/In Memoriam
Connect
Advertise
Contact Us
Daily Headlines Email
Support Local News
Search Type
Site
Search
Home
Submissions
Report a Typo or Mistake
Report a Typo or Mistake
Your Name
Optional
Your Email
Optional
Your Phone
Optional
Title
FDA approves a second Alzheimer's drug that can modestly slow disease
Link
Typo or Mistake
Verify
Submit Report
